Skip to main content
Aurobindo Pharma Limited (NSE:AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,150.20
-5.00 (-0.43%)
Jun 13, 2025, 3:30 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
Generic Pharmaceuticals and Related Services
 		282.23B
Log In
Log In
Log In
Log In
Upgrade
Generic Pharmaceuticals and Related Services Growth
 		17.09%
Log In
Log In
Log In
Log In
Upgrade
Services
4.81B
Log In
Log In
Log In
Log In
Upgrade
Services Growth
-6.15%
Log In
Log In
Log In
Log In
Upgrade
Government Incentive Schemes
2.77B
Log In
Log In
Log In
Log In
Upgrade
Government Incentive Schemes Growth
27.20%
Log In
Log In
Log In
Log In
Upgrade
Scrap
206.00M
Log In
Log In
Log In
Log In
Upgrade
Scrap Growth
-0.34%
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
United States
139.80B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
24.36%
Log In
Log In
Log In
Log In
Upgrade
Europe
75.63B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
4.42%
Log In
Log In
Log In
Log In
Upgrade
Rest of the World
40.56B
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Growth
11.98%
Log In
Log In
Log In
Log In
Upgrade
India
34.02B
Log In
Log In
Log In
Log In
Upgrade
India Growth
23.79%
Log In
Log In
Log In
Log In
Upgrade